Valeo Management and its exclusive worldwide licensee FITTnLEAN, which markets Adipotronics, the patented targeted fat loss technology, announce the closing of a $1,000,000 investment by Partner One Capital.

The technology uses an electrical stimulator, which induces targeted fat loss through a gentle electric current in areas designated by the user during physical activity. It was invented by researchers from the Departments of Kinanthropology and Biological Sciences of the University of Québec at Montréal (UQAM).

In 2012, FITTnLEAN successfully completed a 10-week triple-blind, randomized, placebo-controlled clinical study on the Adipotronics technology, showing impressive targeted fat loss results.

FITTnLEAN will be launching Adipotronics, the targeted fat loss technology, in late 2013.

About FITTnLEAN
FITTnLEAN is the exclusive worldwide licensee of Adipotronics, the targeted fat loss technology. FITTnLEAN specializes in the development and commercialization of patented and/or innovative products and services in the areas of health, fitness and aesthetics. (www.FittnLean.com)

About Partner One Capital
With current assets of $1.4 Billion, Partner One Capital is currently the world's largest self-funded private investment firm focusing solely on marketing-driven businesses. Since 1995, Partner One Capital has established itself as a leading investment firm and partner, with a solid track record of success in private equity, venture capital and angel investments. (www.PartnerOneCapital.com)